The U.S. vitamin market and the global sexual health supplement market are both forecast to grow, driven by preventive health, personalization and e-commerce. Market reports project vitamins reaching USD 22.72 billion by 2034 and sexual health supplements reaching $5.31 billion by 2030.
US health policy activity this week included HHS FY 2027 budget hearings, a House review of Medicare fraud and bipartisan discussion of PBM reform. President Trump also issued an executive order on mental illness treatments, and CMS and FDA announced the RAPID pathway.
Bio-Thera Solutions expands its partnership with Intas Pharmaceuticals for BAT2506, a golimumab biosimilar, through an exclusive commercialization agreement for India. The India biosimilars market is projected to grow from $184 million to $1.02 billion by 2035, driven by patent expirations and strategic partnerships.
India's pharmaceutical industry, valued at Rs. 5.41 lakh crore in 2025, is transitioning from a generics powerhouse to an innovation-driven sector focused on biosimilars, complex formulations, and global R&D capabilities.
New market reports forecast significant expansion in CAR T-cell therapy, US pharmaceutical drug delivery, and healthcare nanotechnology sectors, driven by chronic disease prevalence and technological advances.
The FDA is expected to issue draft guidance reducing testing requirements for biosimilar drugs, potentially lowering development costs by USD 20 million. The move comes as the biosimilars market shows strong growth, with major launches in 2025.
AstraZeneca announced a $15 billion investment in Chinese R&D facilities through 2030, elevating China to a global innovation hub, while former China chief Leon Wang faces charges for unlawful data collection, illegal trade, and medical insurance fraud.
The global mRNA and next-generation vaccine platforms market is expected to grow from $39.69 billion in 2025 to $82.61 billion by 2030 at a 15.8% CAGR, driven by personalized medicine demand and infectious disease applications, while safety concerns and regulatory scrutiny continue.
The global oncology market is projected to nearly triple from $279.98 billion in 2026 to $748.17 billion by 2035, driven by rapid adoption of immunotherapy, checkpoint inhibitors, and cell therapies across solid tumors and hematologic cancers.
The global biotechnology market is undergoing a transformation from discovery-based science to precision engineering, driven by AI, synthetic biology, and gene editing technologies, with projected growth of 13-15% over the next five years.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07672704 |
AI-Based Tai Chi and Baduanjin for Improving Balance and Reducing Fall Risk in Adults With Chronic Diseases |
NOT_YET_RECRUITING | NA |
| NCT07645911 |
Gansu Nurses' Health Cohort Study |
NOT_YET_RECRUITING | |
| NCT07635355 |
Real-World Data Linkage Research Platform |
NOT_YET_RECRUITING | |
| NCT07601308 |
Impact of Online Medical Misinformation |
COMPLETED | |
| NCT06996899 |
Physical Health Improvement Intervention for People Admitted to Mental Health Service |
NOT_YET_RECRUITING | NA |
| NCT06179238 |
Urinary Catheter Self-care Management |
COMPLETED | NA |
| NCT06046326 |
Evaluate the Effectiveness of a Virtual Community of Practice |
RECRUITING | NA |
| NCT05247632 |
Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study |
ACTIVE_NOT_RECRUITING | |
| NCT04750915 |
NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data |
ACTIVE_NOT_RECRUITING | |
| NCT02885129 |
Development of the General Scale Observance for Chronic Diseases |
COMPLETED |
